Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Synthetic Proteins and Peptides for the Direct Interrogation of α-Synuclein Posttranslational Modifications
View through CrossRef
α-Synuclein is the aggregation-prone protein associated with Parkinson’s disease (PD) and related neurodegenerative diseases. Complicating both its biological functions and toxic aggregation are a variety of posttranslational modifications. These modifications have the potential to either positively or negatively affect α-synuclein aggregation, raising the possibility that the enzymes that add or remove these modifications could be therapeutic targets in PD. Synthetic protein chemistry is uniquely positioned to generate site-specifically and homogeneously modified proteins for biochemical study. Here, we review the application of synthetic peptides and proteins towards understanding the effects of α-synuclein posttranslational modifications.
Title: Synthetic Proteins and Peptides for the Direct Interrogation of α-Synuclein Posttranslational Modifications
Description:
α-Synuclein is the aggregation-prone protein associated with Parkinson’s disease (PD) and related neurodegenerative diseases.
Complicating both its biological functions and toxic aggregation are a variety of posttranslational modifications.
These modifications have the potential to either positively or negatively affect α-synuclein aggregation, raising the possibility that the enzymes that add or remove these modifications could be therapeutic targets in PD.
Synthetic protein chemistry is uniquely positioned to generate site-specifically and homogeneously modified proteins for biochemical study.
Here, we review the application of synthetic peptides and proteins towards understanding the effects of α-synuclein posttranslational modifications.
Related Results
Novel β-synuclein Rearrangements in tumor
Novel β-synuclein Rearrangements in tumor
Abstract
Purpose
The synuclein family includes a-, b-, g-synuclein and is predominantly expressed in neurons. a- and b-synuclein is mutated in Parkinson's disease and demen...
The Small Molecule Alpha-Synuclein Aggregator, FN075, Enhances Alpha-Synuclein Pathology in Subclinical AAV Rat Models
The Small Molecule Alpha-Synuclein Aggregator, FN075, Enhances Alpha-Synuclein Pathology in Subclinical AAV Rat Models
Animal models of Parkinson’s disease, in which the human α-synuclein transgene is overexpressed in the nigrostriatal pathway using viral vectors, are widely considered to be the mo...
Abstract 1575: Knocking out alpha synuclein causes decreased release of extracellular vesicles in melanoma cells
Abstract 1575: Knocking out alpha synuclein causes decreased release of extracellular vesicles in melanoma cells
Abstract
The purpose of this study is to understand the role of α-synuclein in the regulation of the trafficking and release of modulators of metastasis in melanoma....
Misfolded α-synuclein causes hyperactive respiration without functional deficit in live neuroblastoma cells
Misfolded α-synuclein causes hyperactive respiration without functional deficit in live neuroblastoma cells
Abstract
The misfolding and aggregation of the largely disordered protein, α-synuclein, is a central pathogenic event that occurs in the synucleinopathies; a group ...
Interneuronal In Vivo Transfer of Synaptic Proteins
Interneuronal In Vivo Transfer of Synaptic Proteins
Neuron-to-neuron transfer of pathogenic α-synuclein species is a mechanism of likely relevance to Parkinson’s disease development. Experimentally, interneuronal α-synuclein spreadi...
A Novel Mouse Model of Parkinson’s Disease for Investigating Progressive Pathology and Neuroprotection
A Novel Mouse Model of Parkinson’s Disease for Investigating Progressive Pathology and Neuroprotection
Abstract
Developing animal models that successfully recapitulate the features of progressive Parkinson’s disease (PD) is crucial for understanding disease progressi...
Alpha‐Synuclein
Alpha‐Synuclein
Abstract
α‐Synuclein (αS) is a presynaptic small protein that has attracted much interest because its aggregation and accumulation in the form o...
α-Synuclein strains that cause distinct pathologies differentially inhibit proteasome
α-Synuclein strains that cause distinct pathologies differentially inhibit proteasome
Abstract
Abnormal α-synuclein aggregation has been implicated in several diseases and is known to spread in a prion-like manner. There is a relationship between pro...